These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 6807788

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Comparative activity of cefsulodin on Pseudomonas aeruginosa, Acinetobacter and Enterobacteriaceae (author's transl)].
    Courtieu AL, Drugeon HB, Bryskier A, Chung SS, Reynaud A.
    Pathol Biol (Paris); 1982 Jun; 30(6):432-9. PubMed ID: 6810287
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of antibacterial activities of cephalosporins].
    Kayser FH, Kohler ML.
    Schweiz Med Wochenschr; 1984 Feb 04; 114(5):156-61. PubMed ID: 6701496
    [Abstract] [Full Text] [Related]

  • 4. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
    Mascellino MT, Prignano G, Iegri F, Lorenzi A.
    Boll Ist Sieroter Milan; 1982 Feb 04; 61(4):309-19. PubMed ID: 6100234
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vitro activity of a new semisynthetic cephalosporin: cefoperazone.
    Auckenthaler R, Waldvogel FA.
    Clin Ther; 1980 Feb 04; 3(Spec Issue):89-97. PubMed ID: 6446401
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative in vitro activities of third-generation cephalosporins.
    Fass RJ.
    Arch Intern Med; 1983 Sep 04; 143(9):1743-5. PubMed ID: 6615095
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of the in vitro activity of new beta-lactams and aminoglycosides against clinical isolates of Pseudomonas aeruginosa.
    Patzer J, Gieburowska R, Dzierzanowska D.
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Oct 04; 253(1):110-20. PubMed ID: 6817544
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.
    Krause R, Mittermayer H, Feierl G, Allerberger F, Wendelin I, Hirschl A, Reisinger EC.
    Wien Klin Wochenschr; 1999 Jul 30; 111(14):549-54. PubMed ID: 10467641
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity of modern penicillins and cephalosporins against enterococci.
    Haller I, Heinrich S.
    Arzneimittelforschung; 1982 Jul 30; 32(7):756-9. PubMed ID: 6812597
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Cefoperazone, cefsulodin and ceftazidime--3 cephalosporins active against Pseudomonas in comparison with their monobactam analogs].
    Baumgärtner M.
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Apr 30; 254(2):253-60. PubMed ID: 6326420
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.